Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Technosphere/Insulin vs. Subcutaneous Insulin in Type 2 Diabetes
NCT00419302Phase 2Completed
- Sponsor
- MannKind
- Start
- Oct 2003
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Technosphere insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by MannKind. Primary endpoint: Glycemic response to a meal challenge. Started Oct 2003; status: completed.
02
Drugs
Technosphere insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00419302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00419302.